Financials
- Market Capitalization 11.34 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
33.02
Relación precio/flujo de caja
3.64
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 814 | AXSM Axsome Therapeutics, Inc. - Common Stock | 235.23 USD | +3.04% | -5.82% | -7.51% | +80.67% | 12.10 B USD | ||
| 818 | SMMT Summit Therapeutics Inc. - Common Stock | 15.47 USD | +1.11% | -2.58% | +7.13% | -22.10% | 12.01 B USD | ||
| 859 | TECH Bio-Techne Corp - Common Stock | 71.24 USD | -0.17% | +0.89% | +28.80% | +34.44% | 11.15 B USD | ||
| 879 | ABVX Abivax SA - American Depositary Shares | 134.89 USD | -0.80% | -5.12% | +35.43% | +1398.78% | 10.59 B USD |